New multivalent antibodies for immunooncology

癌症现在是澳大利亚人的头号杀手，开发安全并最大化抗癌功效的新疗法的医疗需求尚未得到满足。癌症免疫治疗现在代表了癌症治疗的第四个新支柱，以补充手术，放疗和化疗/靶向治疗。该应用旨在开发新的治疗方法，以扩大癌症免疫治疗的有效性，并可能允许治疗更广泛的癌症和患者。

Cancer is now the number one killer of Australians and there is an unmet medical need to develop new therapies that are safe and maximize anti-cancer efficacy. Cancer immunotherapy now represents a new fourth pillar in cancer treatment to complement surgery, radiotherapy and chemo-/targeted therapies. This application aims to develop new therapeutic approaches to broaden the effectiveness of cancer immunotherapy and potentially allow the treatment of a broader range of cancers and patients.